314 Results for "

il17

" in MedChemExpress (MCE) Product Catalog:
Products (314)

314 Results for "il17" in MCE Product Catalog:

24
24 Publications Verification
Cat. No.: HY-15826
CAS No.: 1613695-14-9
Purity:  99.60%
SGC-CBP30, a chemical probe, is a potent and highly selective CBP/p300 bromodomain (Kds of 21 nM and 32 nM for CBP and p300, respectively) inhibitor, displaying 40-fold selectivity over the first bromodomain of BRD4 [BRD4(1)] bound. SGC-CBP30 strongly reduces secretion of IL-17A in Th17 cells and has anti-inflammatory effects .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-P70527
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Interleukin-17A; il-17; il-17A; Cytotoxic T-Lymphocyte-Associated Antigen 8; CTLA-8; il17A; CTLA8; il17
Species:  
Source:  
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-P9927A
CAS No.: 1229022-83-6

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Secukinumab (Anti-Human IL-17A) is a fully human anti-interleukin-17A monoclonal antibody. Anti-Human IL-17A can be used for research in psoriasis pathogenesis .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-P9927
CAS No.: 1229022-83-6
Synonyms: AIN457

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology Cancer

Secukinumab (AIN457) is a high affinity, human monoclonal antibody targeted against interleukin (IL)-17A. Secukinumab is the first-in-class anti-IL-17 agent used for the research of plaque psoriasis, ankylosing spondylitis and psoriatic arthritis .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-15898
CAS No.: 288250-47-5
Purity:  99.03%
Y-320 is a potent, orally active phenylpyrazoleanilide immunomodulator. Y-320 inhibits IL-17 production by CD4 T cells stimulated with IL-15 with IC50 values of 20 to 60 nM. Y-320 enhances TP53, DMD, and COL17A1 PTC readthrough by G418 and increases cellular protein levels and protein synthesis. Y-320 concomitants use of with a low dose of Paclitaxel (HY-B0015) significantly sensitized multidrug resistance (MDR) tumors by inducing G2/M phase arrest and apoptosis. Y-320 can be used for research of rheumatoid arthritis (RA) and cancer .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-P7036
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuil-17; il-17A; Cytotoxic T-lymphocyte-associated antigen 8; CTLA-8
Species:  
Source:  
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-P70753
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Interleukin-17A; il-17; il-17A; Cytotoxic T-Lymphocyte-Associated Antigen 8; CTLA-8; il17A; CTLA8; il17
Species:  
Source:  
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-N9965
CAS No.: 41263-94-9
Synonyms: 2'-FL
2'-Fucosyllactose (2'-FL) is an oligosaccharide that could be derived from human milk. 2'-Fucosyllactose regulates the expression of CD14, alleviates colitis and regulates the gut microbiome. 2'-Fucosyllactose stimulates T cells to increase IFN-γ production and decreases IL-6, IL-17, and TNF-α production of cytokines .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-139206
CAS No.: 2452464-73-0
Purity:  99.65%
Synonyms: il-17A inhibitor 1
Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

LY3509754 (IL-17A inhibitor 1) is a IL-17A inhibitor, with IC50 values of <9.45 nM and 9.3 nM in alphalisa assay and HT-29 cells .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-19770
CAS No.: 1474110-21-8
Target:  

ROR

Research Areas:  

Inflammation/Immunology

GSK2981278 is a potent and selective RORγ inverse agonist. GSK2981278 inhibits activation of the il17 promoter and interferes RORγ-DNA binding .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101913
CAS No.: 2205034-18-8
Purity:  99.74%
IL-17A antagonist 1 (Compound 1) is an IL-17A antagonist, with a Kd of 0.66 μM and an IC50 of 1.14 μM .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P79326
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: il17a; interleukin 17A; il17; il-17; CTLA-8; il-17A; interleukin-17A; Interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8); cytotoxic T-lymphocyte-associated antigen 8; Interleukin 17
Species:  
Rat
Source:  
CHO
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P9924
CAS No.: 1143503-69-8
Synonyms: LY2439821

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Ixekizumab (LY2439821) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM). Ixekizumab directly blocks IL-17A binding to IL-17RA (IL-17A receptor) but does not bind to other IL-17 family members. Ixekizumab is used for the research of moderate-to-severe plaque psoriasis .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P700194AF
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CTLA8; CTLA-8; il-17; Interleukin-17A; il17A
Species:  
Source:  
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101454
CAS No.: 303126-97-8
Purity:  99.65%
Target:  

ROR

Research Areas:  

Inflammation/Immunology Cancer

SR0987, a SR1078 analog, is a RORγt agonist, with an EC50 of 800 nM. SR0987 increases IL17 expression while repressing the expression of PD-1 .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-107390
CAS No.: 1370544-73-2
Purity:  99.29%
AX-024 is an orally available, first-in-class inhibitor of the TCR-Nck interaction that selectively inhibits TCR-triggered T cell activation with an IC50 ~1 nM. AX-024 modulates cell signaling by targeting SH3 domains. AX-024 has low-acute toxicity and high potency and selectivity, and strongly inhibit the production of IL-6, TNF-α, IFN-γ, IL-10 and IL-17A.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-107390A
CAS No.: 1704801-24-0
Purity:  99.75%
AX-024 hydrochloride is an orally available, first-in-class inhibitor of the TCR-Nck interaction that selectively inhibits TCR-triggered T cell activation with an IC50 ~1 nM. AX-024 hydrochloride modulates cell signaling by targeting SH3 domains. AX-024 hydrochloride has low-acute toxicity and high potency and selectivity, and strongly inhibit the production of IL-6, TNF-α, IFN-γ, IL-10 and IL-17A.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-116330A
CAS No.: 238074-03-8
Purity:  99.52%
Synonyms: Hyperforin DCHA
Hyperforin dicyclohexylammonium salt (Hyperforin DCHA) is a transient receptor canonical 6 (TRPC6) channels activator. Hyperforin dicyclohexylammonium salt modulates Ca 2+ levels by activating Ca 2+-conducting non-selective canonical TRPC6 channels. Hyperforin dicyclohexylammonium salt also shows diverse pharmacological activities including anti-depression, anti-tumor, anti-dementia, anti-diabetes. Hyperforin dicyclohexylammonium salt modulates γδ T cells to secret IL-17α, improves Imiquimod (HY-B0180)-induced psoriasis-like mice model .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-145429
CAS No.: 2748749-47-3
Purity:  98.44%
IL-17A modulator-2 is a IL-17A modulator, extracted from patent WO2021239743+A1, example 27. IL-17A modulator-2 inhibits the biological action of IL-17A with a pIC50 of 8.3. IL-17A modulator-2 can be used for the research of diseases or disorders associated with modulation of IL-17A activity including diseases with an immune component or autoimmune pathol, cancer and neurodegenerative disorders .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P71963
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CANDF5; CD217; CD217 antigen; CDw217; CTLA8; Hil 17R; hil17R; I17RA_HUMAN; il 17 receptor A; il 17 receptor; il 17RA; il-17 receptor A; il-17RA; il17; il17A receptor; il17R; il17RA; IMD51; Interleukin 17 receptor A; Interleukin-17 receptor A; MGC10262
Species:  
Source:  
loading...
    loading...